Mary Glenn Fowler
Biographic Data
| ID | 5992408 |
|---|---|
| NAME | Mary Glenn Fowler |
| GIVEN NAMES | Mary Glenn |
| FAMILY NAME | Fowler |
| SIGNATURE | FOWLER M G |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0003-4484-9009 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 11 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1995 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
‘When I receive ARVs through my group, my heart settles’: Participants’ perceptions and experiences of Friends for Life Circles for Option B+ in Kampala and Mityana Districts, Uganda
The Friends for Life Circles (FLC) was a parallel randomized controlled trial testing the efficacy of a group peer support intervention to support long-term adherence to Option B+ in Kampala and Mityana districts in Uganda. We explored FLC participants’ experiences and perceptions of the intervention on adherence to Option B+ for PMTCT and potential implications for strengthening the PMTCT program. We collected data from six focus group discussio…
PMTCT Option B+ 2012 to 2018 — Taking stock: Barriers and strategies to improve adherence to Option B+ in urban and rural Uganda
Since 2012, PMTCT Option B+ has been recommended by the World Health Organization to reduce vertical transmission but numerous adherence challenges remain. We conducted a qualitative study at baseline using six focus group discussions and 14 in-depth interviews to explore knowledge, beliefs, attitudes and challenges towards the Option B+ strategy for PMTCT among HIV-infected pregnant and post-partum women and health workers engaged in Uganda's na…
Repeat] testing and counseling is one of the key [services] that the government should continue providing”: Participants’ perceptions on extended repeat HIV testing and enhanced counseling (ERHTEC) fo…
ClinicalTrials.gov registration number NCT01882998, date of registration 21st June 2013
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe
The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …
A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
Results from this study show high overall HIV disclosure proportions and how this disclosure of HIV status can foster social support. However, proportions of disclosure specifically to male sex partners were low, which suggests the need for interventions aimed at increasing male involvement in perinatal care, along with supportive counseling
Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004–2009
Pediatricians’ Role and Practices Regarding Provision of Guidance about Sexual Risk Reduction to Parents
Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries: Translating Research Into Policy and Practice
Each year, an estimated 590,000 infants acquire human immunodeficiency virus type 1 (HIV) infection from their mothers, mostly in developing countries that are unable to implement interventions now standard in the industrialized world. In resource-poor settings, the HIV pandemic has eroded hard-won gains in infant and child survival. Recent clinical trial results from international settings suggest that short-course antiretroviral regimens could …
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: Hivnet 012 randomised trial
Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child
Background A substantial proportion of perinatally acquired infections with the human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, which suggests that obstetrical factors may have an important influence on transmission. We evaluated the relation of such factors and other variables to the perinatal transmission of HIV-1. Methods The Women and Infants Transmission Study is a prospective, observational study of HIV-1–infected wom…
Hardy and Fowler Respond
Hardy and Fowler Respond Ann M. Hardy, and Mary Glenn Fowler CopyRight https://doi.org/10.2105/AJPH.85.2.267-a Published Online: October 07, 2011
No prominent works on this page.
Hardy and Fowler Respond
Hardy and Fowler Respond Ann M. Hardy, and Mary Glenn Fowler CopyRight https://doi.org/10.2105/AJPH.85.2.267-a Published Online: October 07, 2011
Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child
Background A substantial proportion of perinatally acquired infections with the human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, which suggests that obstetrical factors may have an important influence on transmission. We evaluated the relation of such factors and other variables to the perinatal transmission of HIV-1. Methods The Women and Infants Transmission Study is a prospective, observational study of HIV-1–infected wom…
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: Hivnet 012 randomised trial
Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries: Translating Research Into Policy and Practice
Each year, an estimated 590,000 infants acquire human immunodeficiency virus type 1 (HIV) infection from their mothers, mostly in developing countries that are unable to implement interventions now standard in the industrialized world. In resource-poor settings, the HIV pandemic has eroded hard-won gains in infant and child survival. Recent clinical trial results from international settings suggest that short-course antiretroviral regimens could …
Pediatricians’ Role and Practices Regarding Provision of Guidance about Sexual Risk Reduction to Parents
A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
Results from this study show high overall HIV disclosure proportions and how this disclosure of HIV status can foster social support. However, proportions of disclosure specifically to male sex partners were low, which suggests the need for interventions aimed at increasing male involvement in perinatal care, along with supportive counseling
Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004–2009
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe
The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …
PMTCT Option B+ 2012 to 2018 — Taking stock: Barriers and strategies to improve adherence to Option B+ in urban and rural Uganda
Since 2012, PMTCT Option B+ has been recommended by the World Health Organization to reduce vertical transmission but numerous adherence challenges remain. We conducted a qualitative study at baseline using six focus group discussions and 14 in-depth interviews to explore knowledge, beliefs, attitudes and challenges towards the Option B+ strategy for PMTCT among HIV-infected pregnant and post-partum women and health workers engaged in Uganda's na…
Repeat] testing and counseling is one of the key [services] that the government should continue providing”: Participants’ perceptions on extended repeat HIV testing and enhanced counseling (ERHTEC) fo…
ClinicalTrials.gov registration number NCT01882998, date of registration 21st June 2013
‘When I receive ARVs through my group, my heart settles’: Participants’ perceptions and experiences of Friends for Life Circles for Option B+ in Kampala and Mityana Districts, Uganda
The Friends for Life Circles (FLC) was a parallel randomized controlled trial testing the efficacy of a group peer support intervention to support long-term adherence to Option B+ in Kampala and Mityana districts in Uganda. We explored FLC participants’ experiences and perceptions of the intervention on adherence to Option B+ for PMTCT and potential implications for strengthening the PMTCT program. We collected data from six focus group discussio…
Medicine (11 works) · HIV/AIDS Research and Interventions (9 works) · Adolescent Sexual and Reproductive Health (8 works) · Nursing (7 works) · Family medicine (6 works) · HIV, Drug Use, Sexual Risk (6 works) · Psychology (5 works) · Public health (5 works) · Antiretroviral therapy (4 works) · Human immunodeficiency virus (HIV (4 works)